A mechanistic study of this unanticipated clinical outcome revealed yet another new molecular biology of the gene and a potential mechanism of immune surveillance against cancers: Under chronic conditions of IFN‐γ stimulated IDO‐1 activity, the tested melanoma cells deplete tryptophan via the kynurenine metabolic pathway. The gene discussed is IFNG; the disease is cancer.